{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:30:04Z","timestamp":1779316204983,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.toxicon.2011.05.012","type":"journal-article","created":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T16:40:22Z","timestamp":1307292022000},"page":"159-167","source":"Crossref","is-referenced-by-count":50,"title":["Characterization of diffusion and duration of action of a new botulinum toxin type A formulation"],"prefix":"10.1016","volume":"58","author":[{"given":"Hongran F.","family":"Stone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thai Q.D.","family":"Thach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis L.","family":"Ruegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2011.05.012_bib1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1152\/jappl.2001.90.5.1900","article-title":"Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse","volume":"90","author":"Allen","year":"2001","journal-title":"J. Appl. Physiol."},{"issue":"12","key":"10.1016\/j.toxicon.2011.05.012_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0041-0101(01)00101-5","article-title":"A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice","volume":"39","author":"Aoki","year":"2001","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/j.toxicon.2011.05.012_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1139\/y89-137","article-title":"Comparison of the effects of botulinum toxin in adult and neonatal rats: neuromuscular blockage and toxicity","volume":"67","author":"Bambrick","year":"1989","journal-title":"Can. J. Physiol. Pharmcol"},{"issue":"6442","key":"10.1016\/j.toxicon.2011.05.012_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2011.05.012_bib5","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","article-title":"Botulinum toxin: chemistry, pharmacology, toxicity, and immunology","volume":"6","author":"Brin","year":"1997","journal-title":"Muscle Nerve Suppl."},{"issue":"3","key":"10.1016\/j.toxicon.2011.05.012_bib6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/mus.21343","article-title":"Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg muscle & nerve","volume":"40","author":"Carli","year":"2009","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1016\/j.toxicon.2011.05.012_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2146\/ajhp050137","article-title":"Unlabeled uses of botulinum toxins: a review, part 1","volume":"63","author":"Cheng","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"3","key":"10.1016\/j.toxicon.2011.05.012_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2146\/sp\/06001","article-title":"Unlabeled uses of botulinum toxins: a review, part 2","volume":"63","author":"Cheng","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2011.05.012_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17429590701523794","article-title":"Diffusion characteristics of outline neurotoxin products and their clinical significance in cosmetic applications","volume":"9","author":"de Almeida","year":"2007","journal-title":"J. Cosmet. Laser Ther."},{"issue":"2","key":"10.1016\/j.toxicon.2011.05.012_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.toxicon.2005.03.022","article-title":"Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle","volume":"46","author":"Dodd","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.05.012_bib11","series-title":"FDA Gives Update on Botulinum Toxin Safety Warnings; Established Names of Drugs Changed","year":"2009"},{"issue":"4","key":"10.1016\/j.toxicon.2011.05.012_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.sder.2008.03.003","article-title":"Update on botulinum toxin","volume":"26","author":"Flynn","year":"2007","journal-title":"Semin. Cutan. Med. Surg."},{"issue":"2\u20133","key":"10.1016\/j.toxicon.2011.05.012_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF03033931","article-title":"Botulinum neurotoxin - from laboratory to bedside","volume":"9","author":"Foster","year":"2006","journal-title":"Neurotox Res."},{"issue":"4","key":"10.1016\/j.toxicon.2011.05.012_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00019052-199408000-00014","article-title":"Botulinum toxin in movement disorders","volume":"7","author":"Jankovic","year":"1994","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.toxicon.2011.05.012_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.neuroscience.2005.12.029","article-title":"Recovery from botulinum neurotoxin poisoning in\u00a0vivo","volume":"139","author":"Keller","year":"2006","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.toxicon.2011.05.012_bib16","doi-asserted-by":"crossref","first-page":"413e","DOI":"10.1097\/PRS.0b013e318170813c","article-title":"Comparisons among botulinum toxins: an evidence-based review","volume":"121","author":"Klein","year":"2008","journal-title":"Plast. Reconstr. Surg."},{"issue":"9421","key":"10.1016\/j.toxicon.2011.05.012_bib17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0140-6736(04)16207-7","article-title":"Cerebral palsy","volume":"363","author":"Koman","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.toxicon.2011.05.012_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0041-0101(02)00370-7","article-title":"Toxicity of botulinum neurotoxins in central nervous system of mice","volume":"41","author":"Luvisetto","year":"2003","journal-title":"Toxicon"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2011.05.012_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/17429590701635515","article-title":"Overview of botulinum neurotoxins","volume":"9","author":"Lowe","year":"2007","journal-title":"J. Cosmet. Laser Ther."},{"issue":"12","key":"10.1016\/j.toxicon.2011.05.012_bib20","first-page":"924","article-title":"Pharmacologic weakening of extraocular muscles","volume":"12","author":"Scott","year":"1973","journal-title":"Invest. Ophthalmol."},{"issue":"12","key":"10.1016\/j.toxicon.2011.05.012_bib21","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/jor.20450","article-title":"Effects of BOTOX\u00ae and Neuronox on muscle force generation in mice","volume":"25","author":"Stone","year":"2007","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.toxicon.2011.05.012_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1152\/physiolgenomics.00243.2004","article-title":"Influence of genetic background on daily running-wheel activity differs with aging","volume":"22","author":"Turner","year":"2005","journal-title":"Physiol. Genomics"},{"issue":"11","key":"10.1016\/j.toxicon.2011.05.012_bib23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.toxicon.2011.05.012_bib24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jbiomech.2007.11.016","article-title":"BOTOX\u00ae produces functional weakness in non-injected muscles adjacent to the target muscle","volume":"41","author":"Yaraskavitch","year":"2008","journal-title":"J. Biomech."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010111001796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010111001796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T08:27:23Z","timestamp":1560241643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010111001796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0041010111001796"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2011.05.012","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}